Coloplast reports ownership shift as Coloplast stock trades at EUR 55.25

Published on 10/05/2026 at 14:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Coloplast Fonden controls 51.36 percent of voting rights after the October 1, 2026 transfer. Coloplast stock costs EUR 55.25 on October 5, 2026 after EUR 55.33, minus 0.14 percent.

Makroaufnahme von durchscheinendem medizinischem Silikonmaterial mit feiner Textur — Coloplast A/S (DK0060448595) als Materialhersteller inspiriert diese Makroaufnahme von weichem transparentem Silikonmaterial mit feiner Textur, Illustration mit AI erstellt.

Coloplast (ISIN DK0060448595) was trading at EUR 55.25 at Lang & Schwarz on October 5, 2026 at 2:17 p.m. CEST, down 0.14 percent versus the EUR 55.33 prior close. The medical technology company reported an ownership shift on October 1, 2026, with Coloplast Fonden indirectly controlling 51.36 percent of voting rights.

Foundation gains voting control

According to Yahoo Finance on October 1, 2026, NPLH Holding transferred its shares in Coloplast Holding to Coloplast Fonden. Following the transfer, the foundation indirectly held 18.46 percent of Coloplast's share capital, while Niels Peter Louis-Hansen held 3.65 percent of voting rights and 1.92 percent of the share capital.

The structure gives the foundation majority voting control through CF Holding af 2026 ApS. For holders of the listed B shares, the change is therefore more significant for governance than for the company's operating performance.

Organic growth holds above reported trend

Coloplast reported 6.00 percent organic growth and a 26.00 percent EBIT margin for the first nine months of fiscal 2025/26, according to Aktiekurseridag. The company retained guidance for 5.00-6.00 percent organic growth and approximately 5.00 percent EBIT growth at constant exchange rates for fiscal 2025/26.

The contrast matters: organic growth was 6.00 percent, while the reported EBIT margin stood at 26.00 percent after special items linked mainly to Kerecis. That combination leaves execution and margin recovery as the more important operating markers ahead of the next annual report.

Annual results due November 3

Coloplast's market capitalization was DKK 92.9 billion as of October 5, 2026. On the Copenhagen market, the stock's 52-week range was DKK 369.70 to DKK 631.40 as of October 4, 2026, placing the DKK 412.50 reference quote below the midpoint of that range.

GlobeNewswire reported on September 24, 2026 that Coloplast plans to publish fiscal 2026 results on November 3, 2026. That date will provide the next full-period test of the company's 5.00-6.00 percent organic-growth outlook.

Coloplast stock stays below prior close

At Lang & Schwarz, Coloplast stock was trading at EUR 55.25 on October 5, 2026 at 2:17 p.m. CEST, down 0.14 percent versus the EUR 55.33 prior close of October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Coloplast stock.